Novavax, Inc.

Novavax, Inc.verified

NVAX

Price:

$8.64

Market Cap:

$1.38B

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical...[Read more]

Industry

Biotechnology

IPO Date

1995-12-05

Stock Exchange

NASDAQ

Ticker

NVAX

The PE Ratio as of December 2024 (TTM) for Novavax, Inc. (NVAX) is -3.96

According to Novavax, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.96. This represents a change of 396.18% compared to the average of -0.80 of the last 4 quarters.

Novavax, Inc. (NVAX) Historical PE Ratio (quarterly & annually)

How has NVAX PE Ratio performed in the past?

The mean historical PE Ratio of Novavax, Inc. over the last ten years is -6.10. The current -3.96 PE Ratio has changed 6.39% with respect to the historical average. Over the past ten years (40 quarters), NVAX's PE Ratio was at its highest in in the March 2022 quarter at 7.19. The PE Ratio was at its lowest in in the June 2020 quarter at -69.71.

Quarterly (TTM)
Annual

Average

-6.10

Median

-2.83

Minimum

-16.15

Maximum

-0.74

Novavax, Inc. (NVAX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Novavax, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.94%

Maximum Annual PE Ratio = -0.74

Minimum Annual Increase = -91.31%

Minimum Annual PE Ratio = -16.15

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.89-27.36%
2022-1.22-79.99%
2021-6.10-59.34%
2020-15.011.94%
2019-0.74-79.98%
2018-3.6886.48%
2017-1.9762.03%
2016-1.22-91.31%
2015-14.02-13.17%
2014-16.15-3.38%

Novavax, Inc. (NVAX) Average PE Ratio

How has NVAX PE Ratio performed in the past?

The current PE Ratio of Novavax, Inc. (NVAX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.74

5-year avg

-4.79

10-year avg

-6.10

Novavax, Inc. (NVAX) PE Ratio vs. Peers

How is NVAX’s PE Ratio compared to its peers?

Novavax, Inc.’s PE Ratio is greater than Moderna, Inc. (-6.85), less than Inovio Pharmaceuticals, Inc. (-0.00), greater than BioNTech SE (-56.04), less than Vaxart, Inc. (-1.89), less than AstraZeneca PLC (31.26),

CompanyPE RatioMarket cap
-6.85$15.23B
-0.00$64.62M
-56.04$27.21B
-1.89$136.76M
31.26$206.60B

Build a custom stock screener for Novavax, Inc. (NVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novavax, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novavax, Inc. (NVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Novavax, Inc.'s PE Ratio?

How is the PE Ratio calculated for Novavax, Inc. (NVAX)?

What is the highest PE Ratio for Novavax, Inc. (NVAX)?

What is the 3-year average PE Ratio for Novavax, Inc. (NVAX)?

What is the 5-year average PE Ratio for Novavax, Inc. (NVAX)?

How does the current PE Ratio for Novavax, Inc. (NVAX) compare to its historical average?